Skip to main content
. 2005 Jan 21;11(3):331–335. doi: 10.3748/wjg.v11.i3.331

Table 1.

References to colorectal cancer and polymorphisms of metabolic enzymes.

References Gene and polymor-phism1 Grouping2 References Gene and polymor-phism1 Grouping2
Carcinogenesis. 1991; 12(1): 25-8 1 B Pharmacogenetics. 1999; 9(2): 165-9 6 B
Carcinogenesis. 1993; 14(9): 1821-4 (abstract) 1 B Cancer-Res 1995; 55(16): 3537-42 3 B
Carcinogenesis. 1995; 16(7): 1655-7 (abstract) 1,2 Am-J-Epi 1997;145 (abstract) 4
Carcinogenesis. 1996; 17(4): 881-4 1,2 B Cancer-Res. 1998; 58(15): 3307-11 3,5 B
Carcinogenesis. 1996; 17(9): 1855-9 1,2 B Int-J-Cancer. 1990; 46(1): 22-30 4 B
Carcino-Terato-Muta 1996; 8(6): 326-332 1 B Cancer-Res. 1991; 51(8): 2098-100 4 B
Can-Epi-Bio-Prev. 1998; 7(11): 1001-5 1,2 B Can-Epi-Bio-Prev. 1994; 3(8): 675-82 4
J-Toxicol-Sci. 1998; 23 Suppl 2140-2 (abstract) 1 Cancer. 1994; 74(12): 3108-12 4 B
Can-Epi-Bio-Prev. 1998; 7(12): 1079-84 (abstract) 1,5 Lancet. 1996; 347(9012): 1372-4 4
Zhengjiang Yixueyuan Xuebao 1998; 8(4): 446-447 1 B Cancer res on prevention and treatment 4 B
1999; 26(3): 232-233
Cancer-Epidemiol-Biomarkers-Prev. 1999; 8(1): 15-24 1,4 B Gut. 1997; 41(2): 229-34 5 B
Cancer-Lett. 1999; 142(1): 97-104 1,2 B Carcinogenesis. 1997l; 18(7): 1351-4 5 B
Exp-Toxicol-Pathol. 1999; 51(4-5): 321-5 (abstract) 1 Carcinogenesis. 1998; 19(1): 37-41 5 B
Can-Epi-Bio-Prev. 1999; 8(4 Pt 1): 289-92 1,2,6 B Pharmacogenetics. 1998; 8(6): 513-7 5
J-UOEH. 1999; 21(2): 133-47 1,2,3,5,6 B Cancer-Res. 1996; 56(21): 4862-4 9 B
Jiangshu Linchuangyixue Zazhi 2000; 4(2): 90-91 1,2 B Cancer-Res. 1997; 57(6): 1098-102 9 B
Anticancer-Res. 2000; 20(1B): 519-22 (abstract) 1 Genet-Test. 1999; 3(2): 233-6 9 B
J-Gast-Hepatol. 2001; 16(6): 631-5 (abstract) 2 Can-Epi-Bio-Prev. 1999; 8(6): 513-8 9
Carcinogenesis. 2001; 22(7): 1053-60 1,2,5,6 B Can-Epi-Bio-Prev. 1999; 8(9): 825-9 10 B
Gastroenterology 1997: 112: A542 (abstract) 2 B Can-Epi-Bios-Prev. 2000 ; 9(8): 855-6 7,8 B
Carcinogenesis. 2001; 88(8): 1323-6 7,8 B
1

Note: 1-GSTM1 deletion, 2-GSTT1 deletion, 3-NAT1*10, 4-NAT2-rapid acetylator phenotype, 5-NAT2-rapid acetylator genotype, 6-GSTP1 lle105Val, 7-CYP1A1 Lle462Val, 8-CYP1A1 MspI*C, 9-METHFR C677T, 10-MTR A2759G

2

Note, Grouping B: The literatures in group B, grouping A: The literatures in group B.

HHS Vulnerability Disclosure